S&P 500
(0.12%) 5 303.27 points

Dow Jones
(0.34%) 40 004 points

Nasdaq
(-0.07%) 16 686 points

Oil
(-0.10%) $79.98

Gas
(1.37%) $2.66

Gold
(0.86%) $2 438.20

Silver
(4.05%) $32.53

Platinum
(0.93%) $1 100.10

USD/EUR
(-0.03%) $0.920

USD/NOK
(-0.05%) $10.67

USD/GBP
(0.03%) $0.787

USD/RUB
(0.09%) $91.05

Realtime updates for Pharnext SA [ALPHA.PA]

Exchange: EURONEXT Industry: Biotechnology

Last Updated17 May 2024 @ 11:35

25% discount on Stockinvest.us - Use code: Podcast

-11.43% € 0.0581

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

Pharnext SA, a clinical-stage biopharmaceutical company, develops therapies for orphan and common neurodegenerative diseases in France. The company's products include SYNGILITY that has completed Phase III trial for the treatment of Charcot-Marie-Tooth disease type 1A; and PXT864, which has completed Phase II clinical trial to treat Alzheimer's disease, as well as Parkinson's disease and amyotrophic lateral sclerosis...

Stats
Today's Volume	174 132
Average Volume	63 685.00
Market Cap	103 918
EPS	€0 ( 2024-05-17 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	0
ATR14	€0.00200 (3.03%)

Volume Correlation

Long: 0.13 (neutral)

Short: -0.56 (weak negative)

Signal:(52.332) Neutral

Pharnext SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Pharnext SA Correlation - Currency/Commodity

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.41
( neutral )

Pharnext SA Financials

Annual	2023
Revenue:	€10 000.00
Gross Profit:	€10 000.00 (100.00 %)
EPS:	€-200.00

FY	2023
Revenue:	€10 000.00
Gross Profit:	€10 000.00 (100.00 %)
EPS:	€-200.00

FY	2022
Revenue:	€558.00
Gross Profit:	€2.26M (404 643.19 %)
EPS:	€-8.32

FY	2021
Revenue:	€84 785.00
Gross Profit:	€0.00 (0.00 %)
EPS:	€-5 033.08

Financial Reports:

No articles found.

Pharnext SA Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pharnext SA

Pharnext SA, a clinical-stage biopharmaceutical company, develops therapies for orphan and common neurodegenerative diseases in France. The company's products include SYNGILITY that has completed Phase III trial for the treatment of Charcot-Marie-Tooth disease type 1A; and PXT864, which has completed Phase II clinical trial to treat Alzheimer's disease, as well as Parkinson's disease and amyotrophic lateral sclerosis. It also develops PLEOTHERAPY, a big genetic data and artificial intelligence platform. Pharnext SA has an agreement with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential use against the COVID-19 virus. The company was founded in 2007 and is headquartered in Issy-Les-Moulineaux, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.